Helicos Biosciences has appointed William Cotter as vice president of operations, the company said last week. Cotter formerly was vice president of operations at Closure Medical Corporation, and before that worked at Sanofi Diagnostics Pasteur. Helicos disclosed Cotter's appointment as part of its announcement that it has begun manufacturing its Heliscope genome sequencer.
Sequenom has elected Kathleen Wiltsey to its board of directors. Wiltsey spent 14 years at Amgen and is a director of Lexicon Pharmaceuticals. In 2006 she took a post as executive director for development and launch of the Archon X Prize for Genomics.
Wiltsey also is president-elect of the board of the Associates of the California Institute of Technology.
Wyeth announced last week the promotion of Mary Katherine Wold to senior vice president of finance. Wold joined Wyeth in 2002 as VP of taxes, and ascended to senior VP of tax and treasury in 2005.
Prior to joining Wyeth, Wold was a partner in the New York law firm of Shearman & Sterling from 1988 through 2000. In her new post, Wold will report to Greg Norden, Wyeth's new chief financial officer. Previously CFO at the company's pharmaceuticals unit, Norden has been with Wyeth since 1989.
Expression Analysis announced this week it has hired C. Anne Pontius to be senior director of quality systems. In this position Pontius will be responsible for overseeing regulatory compliance and quality assessments activities in the company’s testing sites. Expression Analysis provides genomic services for clinical trials using Affymetrix GeneChip, Illumina BeadArray, Luminex xMAP and Applied Biosystems’ TaqMan technologies.
Pontius is currently the president elect of the Clinical Laboratory Management Association. She was also president and principal consultant of Laboratory Compliance Consultants, a firm specializing in regulatory compliance for clinical laboratories.